methylprednisolone acetate has been researched along with Bone Loss, Osteoclastic in 2 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, HX | 1 |
| Huang, YX | 1 |
| Tao, JG | 1 |
| Nitta, T | 1 |
| Fukushima, T | 1 |
| Nakamuta, H | 1 |
| Koida, M | 1 |
2 other studies available for methylprednisolone acetate and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
ST1926 Attenuates Steroid-Induced Osteoporosis in Rats by Inhibiting Inflammation Response.
Topics: Adamantane; Alkaline Phosphatase; Animals; beta Catenin; Bone Density; Bone Density Conservation Age | 2017 |
Glucocorticoid-induced secondary osteopenia in female rats: a time course study as compared with ovariectomy-induced osteopenia and response to salmon calcitonin.
Topics: Analgesics; Animals; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Bone Resorption; Calci | 1999 |